Active Comparator Biological/Vaccine,Experimental Biological/Vaccine

5 trials

Sponsors

Research Promotion Commitee of Lampang Hospital, Siriraj Research Fund, National Vaccine Institute, The National Vaccine Institute (NVI), Thailand, Ministry of Economy, Trade and Industry (METI)

Conditions

Dry eye disease Concentration of epitheliotrophic growth factors in PRP and AS Efficacy in treatment of DED of PRP and AS Stability of epitheliotrophic growth factors in PRP and AS epitheliotrophic growth factor autologous serum platelet&#45Healthy Thai children aged 5-11 years who were previously infected with SARS-CoV-2 children, previous infection, SARS-CoV-2, COVID-19, vaccines, mRNA vaccines, Adverse events, Vaccine safetyIncindence of pseudathrosis of laminectomy with posterolateral fusion with instrumentation pseudathrosis&#44Persons who have high risk of developing HCC Early HCC detection, AFP, PIVKAII, AFP-L3, GALAD score,Prevention of COVID-19 with booster SARS-CoV-2 vaccine using BNT162b2, comparing standard dose vs low dose, in elderly or adult with underlying diseases. SARS-CoV-2, mRNA vaccine, ChAdOx1 nCoV-19 vaccine, Immunogenicity, Reactogenicity

Early Phase 1

Comparison of Concentration of Epitheliotrophic Growth Factors in Platelet-Rich Plasma and Autologous Serum and the Efficacy in Dry Eye Disease

RecruitingTCTR20191119001

Siriraj Research FundDry eye disease Concentration of epitheliotrophic growth factors in PRP and AS Efficacy in treatment of DED of PRP and AS Stability of epitheliotrophic growth factors in PRP and AS epitheliotrophic growth factor autologous serum platelet&#45

Start: 2019-11-08Target: 10Updated: 2026-08-03

Phase 2

Immunogenicity after booster dose with mRNA BNT162b2 among elderly or adult with underlying diseases who had received AZD1222 using standard versus low dose via intramuscular route (COVID-19)

Active, not recruitingTCTR20211027002

National Vaccine InstitutePrevention of COVID-19 with booster SARS-CoV-2 vaccine using BNT162b2, comparing standard dose vs low dose, in elderly or adult with underlying diseases. SARS-CoV-2, mRNA vaccine, ChAdOx1 nCoV-19 vaccine, Immunogenicity, Reactogenicity

Start: 2021-11-24Target: 200Updated: 2026-08-03

Phase 3

Combination of ultrasonography with alpha-fetoprotein, lecithin-bound alpha-fetoprotein, and des-gamma-carboxy prothrombin for hepatocellular carcinoma surveillance in Thailand; A multi-centered randomized controlled trial

Active, not recruitingTCTR20251127008

Ministry of Economy, Trade and Industry (METI)Persons who have high risk of developing HCC Early HCC detection, AFP, PIVKAII, AFP-L3, GALAD score,

Start: 2021-04-01Target: 3124Updated: 2026-08-03

Phase 4

Antibody responses to mRNA COVID-19 vaccine (BNT162b2) in Thai children aged 5-11 years who were previously infected with SARS-CoV-2.

Active, not recruitingTCTR20230123005

The National Vaccine Institute (NVI), ThailandHealthy Thai children aged 5-11 years who were previously infected with SARS-CoV-2 children, previous infection, SARS-CoV-2, COVID-19, vaccines, mRNA vaccines, Adverse events, Vaccine safety

Start: 2022-03-06Target: 200Updated: 2026-08-03

Unknown Phase

Comparative study of using local bone graft plus hydroxyapatite with or without bone marrow aspiration from vertebral body in posterolateral lumbar fusion: a randomized controlled trail

RecruitingTCTR20191028002

Research Promotion Commitee of Lampang HospitalIncindence of pseudathrosis of laminectomy with posterolateral fusion with instrumentation pseudathrosis&#44

Start: 2018-07-04Target: 98Updated: 2026-08-03